Table 1.
Variable | 2019 (n = 105) | 2020 (n = 119) | p value |
---|---|---|---|
Diagnosis | |||
TBI | 56 (53%) | 67 (56%) | 0.656 |
SAH | 49 (47%) | 52 (44%) | |
Interval | |||
Early | 53 (50%) | 61 (51%) | 0.907 |
Late | 52 (50%) | 58 (49%) | |
Age (median (IQR)) | 50 (62, 72) | 56 (44, 71) | 0.163 |
Female (n (%)) | 44 (42%) | 45 (38%) | 0.533 |
GCS score (n (%)) | |||
3–8 | 39 (37%) | 37 (31%) | 0.480 |
9–12 | 18 (17%) | 18 (15%) | |
13–15 | 48 (46%) | 64 (54%) | |
Pupillary light reaction (n (%)) | |||
Normal | 87 (83%) | 95 (80%) | 0.563 |
Abnormal | 18 (17%) | 24 (20%) | |
Days in ICU (median (IQR)) | 5 (3, 9) | 5 (2, 12) | 0.988 |
SARS-CoV-2 testeda (n (%)) | NA | 24 (20%) | NA |
SARS-CoV-2 positiveb (n (%)) | NA | 0 (0%) | NA |
Early interval includes weeks 1 to 11 and late interval includes weeks 12 to 22
Abbreviation: GCS, Glasgow Coma Scale; ICU, intensive care unit; TBI, traumatic brain injury; SAH, aneurysmal subarachnoid hemorrhage
aTested during the initial admission
bOf tested